Chromogranin A as a valid marker in oncology: Clinical application or false hopes?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Methodol. Mar 26, 2017; 7(1): 9-15
Published online Mar 26, 2017. doi: 10.5662/wjm.v7.i1.9

Table 1 Non cancerous causes of chromogranin A elevation

Disease
Cardiovascular	Endocrine	Gastrointestinal	Inflammatory
Acute coronary syndrome	Hyperparathyroidism	Chronic atrophic gastritis	Chronic bronchitis
Arterial hypertension	Hyperthyroidism	Chronic hepatitis	Chronic obstructive pulmonary disease
Cardiac insufficiency	Hypercortisolism	Inflammatory/irritable bowel syndrome	Giant cell arthritis
		Liver cirrhosis	Rheumatoid arthritis
		Pancreatitis	Systemic inflammatory response syndrome
Drugs
Corticoids	H2 receptor antagonist	Proton pump inhibitor
Status
Exercise	Ingestion of a meal	Pregnancy
Factors having potential influence on sample
Fibrin presence	Haemolysis	Imposing effect: Autoantibodies presence (RF-IgM, Avidine, Heterofile)	Late afternoon/night > morning
Lipaemia	Plasma > serum	-

Citation: Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes? World J Methodol 2017; 7(1): 9-15
URL: https://www.wjgnet.com/2222-0682/full/v7/i1/9.htm
DOI: https://dx.doi.org/10.5662/wjm.v7.i1.9

Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes? World J Methodol 2017; 7(1): 9-15 [PMID: 28396845 DOI: 10.5662/wjm.v7.i1.9]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.